SEC 13F Intelligence

D. E. Shaw & Co., Inc. / CELG

D. E. Shaw & Co., Inc.’s Celgene Corp Position

Does D. E. Shaw & Co., Inc. own Celgene Corp (CELG)? Not currently — the last reported position was 4.63M shares worth $460M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$460M
Q3 2019
Shares
4.63M
% of Portfolio
+0.57%
Quarters Held
4
position exited

Position History CELG

Reported value by quarter
Q4 ’18: $454MQ4 ’18Q1 ’19: $693MQ1 ’19Q2 ’19: $340MQ2 ’19Q3 ’19: $460MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20194.63M$460M+0.57%
Q2 20193.68M$340M+0.42%
Q1 20197.35M$693M+0.90%
Q4 20187.09M$454M+0.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See D. E. Shaw & Co., Inc.’s full portfolio or all institutional holders of CELG.